BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 283 filers reported holding BIONTECH SE in Q1 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,728 | +0.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $21,586 | -13.4% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $24,914 | -17.1% | 200 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $30,044 | -26.7% | 200 | -34.0% | 0.00% | -33.3% |
| Q3 2022 | $41,000 | -8.9% | 303 | +1.0% | 0.01% | 0.0% |
| Q2 2022 | $45,000 | -11.8% | 300 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $51,000 | -44.0% | 300 | -14.3% | 0.01% | -40.0% |
| Q4 2021 | $91,000 | -5.2% | 350 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $96,000 | +21.5% | 350 | 0.0% | 0.01% | +33.3% |
| Q2 2021 | $79,000 | +107.9% | 350 | 0.0% | 0.01% | +80.0% |
| Q1 2021 | $38,000 | +35.7% | 350 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $28,000 | +16.7% | 350 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $24,000 | +4.3% | 350 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $23,000 | +91.7% | 350 | +75.0% | 0.00% | +33.3% |
| Q1 2020 | $12,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $22,333,808 | 17.21% |
| Quinn Opportunity Partners LLC | 262,071 | $39,368,306 | 4.82% |
| Temasek Holdings (Private) Ltd | 4,378,022 | $657,666,465 | 3.84% |
| PARUS FINANCE (UK) Ltd | 29,988 | $4,504,797 | 3.06% |
| Top Ace Asset Management Ltd | 20,000 | $3,004,400 | 2.21% |
| Artia Global Partners LP | 37,108 | $5,574,364 | 2.12% |
| Boston Common Asset Management, LLC | 269,803 | $40,530 | 1.94% |
| FLOSSBACH VON STORCH AG | 3,282,723 | $493,130,649 | 1.88% |
| Redwood Investments, LLC | 87,540 | $13,150,259 | 1.76% |
| Baader Bank Aktiengesellschaft | 238,800 | $35,881,130 | 1.74% |